A cumulative score based on preoperative fibrinogen and the neutrophil–lymphocyte ratio to predict outcomes in resectable gastric cancer

References

• KarimiPIslamiFAnandasabapathySFreedmanNDKamangarFGastric cancer: descriptive epidemiology, risk factors, screening, and preventionCancer Epidemiol Biomarkers Prev201423570071324618998
   PubMed Web of Science ®Google Scholar
• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• IchikawaDKomatsuSKosugaTClinicopathological characteristics of clinical early gastric cancer in the upper-third stomachWorld J Gastroenterol20152145128511285626668509
   PubMed Web of Science ®Google Scholar
• RoukosDHCurrent advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancerAnn Surg Oncol199961465610030415
   PubMed Web of Science ®Google Scholar
• CuschieriAWeedenSFieldingJPatient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative GroupBr J Cancer1999799–101522153010188901
   PubMed Web of Science ®Google Scholar
• PiciucchiMStiglianoSArchibugiLThe neutrophil/lymphocyte ratio at diagnosis is significantly associated with survival in metastatic pancreatic cancer patientsInt J Mol Sci2017184730
   PubMed Web of Science ®Google Scholar
• KitanoYYamashitaYIYamamuraKEffects of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios on survival in patients with extrahepatic cholangiocarcinomaAnticancer Res2017373229323728551669
   PubMed Web of Science ®Google Scholar
• YodyingHMatsudaAMiyashitaMPrognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysisAnn Surg Oncol201623264665426416715
   PubMed Web of Science ®Google Scholar
• ZhangXZhangWFengLJPrognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysisPLoS One2014911e11190625401500
   PubMed Web of Science ®Google Scholar
• TennentGABrennanSOStangouAJO’GradyJHawkinsPNPepysMBHuman plasma fibrinogen is synthesized in the liverBlood20071091971197417082318
   PubMed Web of Science ®Google Scholar
• PerisanidisCPsyrriACohenEEPrognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysisCancer Treat Rev20154196097026604093
   PubMed Web of Science ®Google Scholar
• TangLLiuKWangJWangCZhaoPLiuJHigh preoperative plasma fibrinogen levels are associated with distant metastases and impaired prognosis after curative resection in patients with colorectal cancerJ Surg Oncol2010102542843220672316
   PubMed Web of Science ®Google Scholar
• ShuY-JWengHBaoR-FClinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro studyBMC Cancer201414156625096189
   PubMedGoogle Scholar
• KijimaTArigamiTUchikadoYCombined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinomaCancer Sci201710819319927889946
   PubMed Web of Science ®Google Scholar
• ArigamiTOkumuraHMatsumotoMAnalysis of the fibrinogen and neutrophil-lymphocyte ratio in esophageal squamous cell carcinoma: a promising blood marker of tumor progression and prognosisMedicine20159442e170226496280
   PubMed Web of Science ®Google Scholar
• ZhangXLong Q. Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patientsMedicine201796e669428445272
   PubMed Web of Science ®Google Scholar
• MeiYZhaoSLuXLiuHLiXMaRClinical and prognostic significance of preoperative plasma fibrinogen levels in patients with operable breast cancerPLoS One2016111e014623326799214
   PubMed Web of Science ®Google Scholar
• WangDSRenCQiuMZComparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancerTumour Biol201233374975622198641
   PubMedGoogle Scholar
• AurelloPTiernoSMBerardiGValue of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancerAnn Surg Oncol20142161998200424515568
   PubMed Web of Science ®Google Scholar
• LeitchEFChakrabartiMCrozierJEComparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancerBr J Cancer20079791266127017923866
   PubMed Web of Science ®Google Scholar
• NealCPCairnsVJonesMJPrognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastasesMed Oncol201532514425807934
   PubMed Web of Science ®Google Scholar
• ColottaFAllavenaPSicaAGarlandaCMantovaniACancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis20093071073108119468060
   PubMed Web of Science ®Google Scholar
• MantovaniAGarlandaCAllavenaPMolecular pathways and targets in cancer-related inflammationAnn Med201042316117020384432
   PubMed Web of Science ®Google Scholar
• KuJHKangMKimHSJeongCWKwakCKimHHThe prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomyBr J Cancer2015112346146725584490
   PubMed Web of Science ®Google Scholar
• HuttererGCSobolevNEhrlichGCPretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinomaJ Clin Pathol201568535135525661796
   PubMed Web of Science ®Google Scholar
• GrenaderTWaddellTPeckittCPrognostic value of neutrophil-to-lymphocyte ratio in advanced oesophagogastric cancer: exploratory analysis of the REAL-2 trialAnn Oncol201627468769226787231
   PubMed Web of Science ®Google Scholar
• ZhangJZhangH-YLiJShaoX-YZhangC-XThe elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysisOncotarget2017840688376884628978160
   PubMedGoogle Scholar
• ChangPHWangCHChenEYGlasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancerChin J Cancer Res20172917217828729767
   PubMed Web of Science ®Google Scholar
• YamamotoMKurokawaYMiyazakiYUsefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer RecurrenceWorld J Surg20164081904190926969673
   PubMed Web of Science ®Google Scholar
• LuoYKimHSKimMLeeMSongYSElevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysisJ Gynecol Oncol2017283e3628382799
   PubMed Web of Science ®Google Scholar
• Simpson-HaidarisPJRybarczykBTumors and fibrinogen. The role of fibrinogen as an extracellular matrix proteinAnn N Y Acad Sci200193640642511460495
   PubMed Web of Science ®Google Scholar
• PalumboJSTalmageKEMassariJVPlatelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cellsBlood200510517818515367435
   PubMed Web of Science ®Google Scholar
• RidkerPMHowardCPWalterVEffects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trialCirculation20121262739274823129601
   PubMed Web of Science ®Google Scholar
• ZhangDZhouXBaoWPlasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinomaOncotarget2015635384103842026334098
   PubMedGoogle Scholar
• ArigamiTUenosonoYIshigamiSA novel scoring system based on fibrinogen and the neutrophil-lymphocyte ratio as a predictor of chemotherapy response and prognosis in patients with advanced gastric cancerOncology201690418619226981856
   PubMed Web of Science ®Google Scholar